HALEO Secures $5.2 Million Seed-Extension Financing
Summary
Many employers describe HALEO as a highly effective physical and mental health solution that carries none of the taboo often associated with workplace assistance programs.This seed-funding extension will fuel HALEOs research and development for new solutions across treatment modalities, such as digital therapeutics, and across underserved clinical fields such as shift work, nightmares, sleep optimization and sleep medication management. This protocol is designed and clinically proven to be effective for first responders, manufacturers, transporters, front-line healthcare professionals and other shift workers.Bradley Smith, HALEOs Founder and CEO, said that the company has been focused on delivering outstanding care for sleep at scale since it was founded in 2015. "David Charbonneau, managing partner at Boreal Ventures, added that "what sets HALEO apart is how its solution integrates professional clinical expertise in sleep into a digital platform. HALEO is a rare type of health benefit: a clinically proven solution that has demonstrated the ability to scale to the point that it significantly and measurably reduces an organizations costs and risks. These factors along with two years of a global pandemic, financial uncertainty, and general stress and mental health impacts all contribute to the increase of sleep disorders.